alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
12/03/2012 08:15 4252271007 ANM7 PAGE 02/03 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

n 

12 

13 

14 

15 

:t6 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

29 

30 

31 

32 

33 

34 

35 

36 

37 

38 

39 

40 

41 

42 

43 

44 

45 

46 

47 

48 

49 

50 

.5l 

52 

53 

ROBERT SPlTZER 

FAA OFFICE OF REGIONAL COUNSEJ .. 

1601 LIND AVE. 1 SW 

RENTON, WASHINGTON 9805 7 

TELEPHONE: 425/227·1417 

FACSIMILE: 425/227-1007 

UNITED STATES OF AMERICA 

DEPARTMENT OF TRANSPORTATION · OFFICE OF HEARINGS 

WASHINGTON, D.C. 

In the Matter of: 

Sky West Airlines, Inc. 

FAA DOCKET Not Assigned 

FAA Case No. 2011NM060063 

FDMS Nos. FAA-2012-0873 

Judge Richard C. Good\Vin 

NOTICE OF APPEARANCE 

PLEASE TAKE NOTICE that the undersigned attorney hereby enters his Notice of 

Appearance ~d directs that all corresponden.ce be sen.t to: 

Robert Spitzer · 

Office of Regional CoWlsel 

Federal Aviation Administration 

1601 Lind Avenue SW 

Renton, W A . 98057 

Phone: (425) 227-1417 

Facsimile: (425) 227-1007 

DATED this 3rd day of December, 2012. 

N.OTICE Of APPEARANCE 

Respectfully submitted: 

Robert Spitzer 

Attomey 

Federal Aviation Administration 

Skywest Airlines- 20!.1NM060063, F AA-2012-0873 

P!igc l of2 

ROBERT SPITZER, FAA ATTOitNOCY 

TEL: 425.227.1.417~ FAX: 425.227.1007 
12/03/2012 08:15 

1 

2 

4252271007 ANM7 

CERTIFICATE OF SERVICE 

3 I hereby certifY that the foregoing Motion to Consolidate has been served via facsimile and 

4 certified mail - Return Receipt Requested this date, to the following: 5 

6 

7 

8 

9 

j,Q 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

2l 

22 

23 

24 

25 

26 

27 

28 

29 

30 

3l 

32 

33 

34 

35 

36 

37 

38 

.3.9 

40 

41 

42 

43 

44 

45 

46 

47 

49 

49 

50 

51 

52 

53 

The Honorable Richru·d C. Goodwin 

Office of Hearings, M-20 

1200 New Jersey Avenue, S.E. 

East Buildi.ng Ground Floor, Rm El2-320 

Washington, D.C. 20590 

TEL: (202) 366-2139 

FAX: (202) 366-7536 

Attn: Heru1ng Docket Clerk~ AGC-430 

Wilbur Wlight Building- Suite 2W1000 

Federal Aviation Administration 

800 Independe11.ce Ave. SW. 

Washington, DC 20591 

FAX: (202) 493-5142 

Todd Emerson, Esq. 

Sky West Airlines 

444 S. River Roa.d 

St. George, UT 84790 

TEL: (435) 634-3530 

FAX: (435) 634~3505 

DATED this 3rd day ofDecen.1ber, 2012. /--~· 

TE RlKIRK 

Office of Regional Counsel (ANM-7) 

Federal Aviation Administration 

1601 Lind Ave. SW · Renton, WA 98057 

(425) 227-2007 

PAGE 03/03 

NOTTC.E OF APPEARANCe 

Skywest Airlines- 2011NM060063, FM~2012·0873 Page2 of2 

R09ERT SPITZER, FAA ATTORNEY 

TEL: 425.227.1417: PA.X: 425.227.1007
<PAGE>   1
                                                                    EXHIBIT 21.1

                           SUBSIDIARIES OF THE COMPANY

MiniMed Distribution Corp., a Delaware corporation

MiniMed International, Inc., a Barbados corporation

MiniMed Development Corp. a Delaware corporation

MiniMed SA, a French corporation

MiniMed GMBH, a German corporation

Dartec AB, a Swedish corporation

MiniMed Medical Supply, Inc., a Florida corporation

Home Medical Supply, Inc., a Georgia corporation

Home Medical Supply, Inc., a Tennessee corporation

Home Medical Supply, Inc., a California corporation

Home Medical Supply of Michigan, Inc., a Michigan corporation

HMS, Inc., an Alabama corporation

MiniMed Pharmacies, Inc., a Florida corporation

South Broward Medical Arts Pharmacy, Inc., a Florida corporation

Clark Pharmacy, Inc., a Georgia corporation

MiniMed Wholesale Co., a Florida corporation

Medical Management & Marketing of South Florida, a Florida corporation

MiniMed Pharmaceutical Manufacturing, Inc., a Florida corporation
§ 524.2350 Tolnaftate cream. ( a ) *Specifications.* The drug contains 1 percent tolnaftate in an anhydrous cream base.
( b ) *Sponsor.* See No. 000061 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Amount.* Apply a small amount of the cream to the affected areas once or twice a day for 2 to 4 weeks.
( 2 ) *Indications for use.* For the treatment of ringworm lesions due to *Microsporum canis* and *Microsporum gypseum.*
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 10972, Feb. 27, 2014]
#### §§ 343.50-343.60 [Reserved]
**Exhibit 32**

**CERTIFICATION PURSUANT TO            18 U.S.C. SECTION 1350            AS ADOPTED PURSUANT TO            SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

          I, Daniel W. Dowe, the Chief Executive Officer and Chief Financial Officer, of American Home Food Products, Inc., (the “Company”), pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, certify that:
|   |   |                                                                                                                                                                                                                                                                                                                                         |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | (1)    | In connection with the Annual Report of the Company on form 10-K for the twelve month period ended May 31, 2008, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), fully complies with the requirements of Section 13(a) and Section 15(d) of the Securities and Exchange Act of 1934; and |
|   |   |                                                                                                                                                                                                                                                                                                                                         |
|   | (2)    | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company for the periods presented therein..                                                                                                                                                       |

          A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
|   |                  |                                    |
|--------|-----------------------|-----------------------------------------|
|   | By:                   |   /s/ Daniel W. Dowe          |
|   |                  |                                         |
|   |                  |   Daniel W. Dowe              |
|   |                  |   Chief Executive Officer and |
|   |                  |   Chief Financial Officer     |
|   |                  |                                    |
|   | Date: August 29, 2008 |

----
### “A **rticles of Incorporation” 2015**  

# BarryAir LLC

**1.) BarryAir LLC is incorporated in Louisiana. 2.) BarryAir LLC is incorporated for an unlim**  **ited duration. 3.) BarryAir LLC is incorporated to participate in all Lawful Business.**  **4.) BarryAir LLC m ailing adress is 210 Rue Chavaniac,**  **L afayette, Louisiana 70508** 
**- 7314**  **5.) BarryAir LLC Owner/Director, i**  **s Barry L. Tanner Sr. 6.) Corporation By Laws: are to conduct and operate business observing all State and Federal Law as closely**  **as possible, with due diligence.**  **7.) Dissolution: The officers of BarryAir LLC reserver the right to dissolve BarryAir LLC for any circumstance dee**  **med worthy. 8.) Indemnification of Officers and Directors: BarryAir shall be held harmless from all claims, losses,**  **expenses, and fees, including attorney fees, costs, and judgm ents that m**  **ay be asserted against BarryAir LLC, BarryAir LLC employees, and BarryAir LLC ag**  **ents. BarryAir LLC: Agents include, 1.) Barry Tanner Jr. 2.) Ulrike Hoffm**  **ann Tanner 10.) Incorporator Inform**  **ation: BarryAir LLC was formed by Barry Tanner Sr. in order to conduct business in a safe and lawful manner.** 
**Barry Tanner Sr. 201 Rue Chavania**  **c Lafayette, Louisiana**  **70508 337** 
**- 315** 
**- 0829**  **barryair@cox.net videodronedude@yahoo.com**
* Pursuant to 5TH CIR. R. 47.5, the court has determined that

this opinion should not be published and is not precedent except

under the limited circumstances set forth in 5TH CIR. R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 01-60114

Summary Calendar

 

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

DUDLEY COTTON,

Defendant-Appellant.

--------------------

Appeal from the United States District Court

for the Southern District of Mississippi

USDC No. 4:00-CR-26-ALL-BN

--------------------

July 13, 2001

Before SMITH, BENAVIDES, and DENNIS, Circuit Judges.

PER CURIAM:*

Dudley Cotton has appealed his conviction for sexual abuse

of a minor in Indian Country, a violation of 18 U.S.C. § 2243(a). 

Cotton contends that the jury should have been instructed that it

could convict him for the lesser offense of abusive sexual

contact under 18 U.S.C. § 2244(a). This issue is without merit. 

Although the jury could have convicted Cotton for violating 18

U.S.C. § 2244(a) under the evidence presented at trial, it could

not also have acquitted Cotton of violating 18 U.S.C. § 2243(a)

under that evidence. The district court did not abuse its
No. 01-60114

-2-

discretion in refusing to give the requested instruction. See

United States v. Estrada-Fernandez, 150 F.3d 491, 494 (5th Cir.

1998). 

Cotton contends that the prosecutor commented improperly in

closing argument on Cotton's failure to testify. This issue is

without merit. The prosecutor argued in closing that Cotton had

not presented any evidence to rebut the victim's testimony that

stains on her shirt were her blood. The prosecutor's comment

went to the failure of the defense to counter the victim's

testimony and was not manifestly intended to remind the jury that

Cotton had not testified. See United States v. Montoya-Ortiz, 7

F.3d 1171, 1178 (5th Cir. 1993); United States v. Wade, 931 F.2d

300, 305 (5th Cir. 1991).

The judgment is AFFIRMED.
§ 556.118 Chloramine-T. ( a ) *Acceptable daily intake (ADI).* The ADI for total residue of chloramine-T is 5 μg/kg of body weight per day.
( b ) *Tolerances.* The tolerance for *para*-toluenesulfonamide (marker residue) is: ( 1 ) *Fish.* Muscle/skin (target tissue): 0.9 ppm.
( 2 ) [Reserved]
( c ) *Related conditions of use.* See § 529.382 of this chapter.
NASA LogoNTRSNTRS - NASA Technical Reports ServerSearchmore_vertCollectionsAboutNewsHelpLogin Back to ResultsTESS Data Release Notes: Sector 4, DR5This release note discusses the science data products produced by the Science Processing Operations Center at Ames Research Center from Sector 4 observations made with the TESS spacecraft and cameras as a means to document instrument performance and data characteristics.Document ID20190001935Acquisition SourceAmes Research CenterDocument TypeTechnical Memorandum (TM)AuthorsFausnaugh, Michael M.*(Massachusetts Institute of Technology (MIT) Cambridge, MA, United States)*Burke, Christopher J.*(Massachusetts Institute of Technology (MIT) Cambridge, MA, United States)*Caldwell, Douglas A.*(Search for Extraterrestrial Intelligence Inst. Mountain View, CA, United States)*Jenkins, Jon M.*(NASA Ames Research Center Moffett Field, CA, United States)*Smith, Jeffrey C.*(Search for Extraterrestrial Intelligence Inst. Mountain View, CA, United States)*Twicken, Joseph D.*(Search for Extraterrestrial Intelligence Inst. Mountain View, CA, United States)*Vanderspek, Roland*(Massachusetts Institute of Technology (MIT) Cambridge, MA, United States)*Doty, John P.*(Noqsi Aerospace Ltd. Billerica, MA, United States)*Ting, Eric B.*(NASA Ames Research Center Moffett Field, CA, United States)*Li, Jie*(Search for Extraterrestrial Intelligence Inst. Mountain View, CA, United States)*Villasenor, Joel S.*(Massachusetts Institute of Technology (MIT) Cambridge, MA, United States)*Date AcquiredMarch 28, 2019Publication DateFebruary 6, 2019Subject CategoryAstronomyReport/Patent NumberNASA/TM-2018-220167ARC-E-DAA-TN65304Funding Number(s)CONTRACT_GRANT: NNX17AK23ACONTRACT_GRANT: SPEC5764WBS: WBS 985788.04.02.03CONTRACT_GRANT: NNG14FC03CDistribution LimitsPublicCopyrightPublic Use Permitted.Technical ReviewNASA Technical ManagementKeywordsTESS MissionTransit SurveyExoplanetsAvailable DownloadsNameType20190001935.pdfSTIcloud_downloadcontent_copyvisibilityRelated RecordsIDRelationTitle20190002535See AlsoTESS Data Release Notes: Sector 1, DR120190002170See AlsoTESS Data Release Notes: Sector 7, DR920190002501See AlsoTESS Data Release Notes: Sectors 1-3, Multi-Sector Search, DR620190001284See AlsoTESS Data Release Notes: Sector 2, DR220190002758See AlsoTESS Data Release Notes: Sectors 1 & 2, Multi-Sector 1-2, DR320190001908See AlsoTESS Data Release Notes: Sector 6, DR820190002566See AlsoTESS Data Release Notes: Sector 8, DR1020190001907See AlsoTESS Data Release Notes: Sector 5, DR720190002502See AlsoTESS Data Release Notes: Sector 3, DR4visibility_offNo Preview Available
 No Fear Act | Freedom of Information Act | Office of the Inspector General | Agency Financial ReportsNASA Web Privacy Policy and Important Notices | NASA Guidelines for Quality of InformationDisclaimers, Copyright, Terms of Use | Accessibility | NASA OCIO | USA.gov | NASA.govContact Us | Site MapSTI LogoNASA Official: JoAnne R. Calhoun Site Curator: STI Compliance and Distribution Services Last Modified: September 12, 2024
---

EXHIBIT 32.1





Certification


Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002


(Subsections
(a) and (b) of Section 1350, Chapter 63 of Title 18, United States
Code)





In
connection with the Quarterly Report on Form 10-Q of Southwall Technologies Inc.
(the “Company”), for the period ended March 31, 2009, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Mr.
Dennis Capovilla, the Principal Executive Officer of the Company, do hereby
certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections
(a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
that:





(1)
  The Report of the Company fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
  The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.





Date: November 24,
      2009
            By:
            /s/   Dennis F.
      CapovillaDennis
      F. Capovilla
              Chief
      Executive Officer





A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.
Order 2012-12-23 

Served: December 29, 2011 

UNITED STATES OF AMERICA

DEPARTMENT OF TRANSPORTATION

OFFICE OF THE SECRETARY

WASHINGTON, D.C.

Issued by the Department of Transportation

on the 28th day of October, 2011

In the matter of the revocation of the certificate 

authority issued to

 ARROW AIR, INC.

pursuant to the provisions of 14 CFR § 204.7

Dockets DOT-OST-1999-5140

 DOT-OST-2004-19398

ORDER REVOKING FOREIGN CERTIFICATE

By Order 2011-10-22, issued October 28, 2011, we revoked the Section 41102 interstate 

certificate of public convenience and necessity issued to Arrow Air, Inc., by Order 2000-8-5.

By this order, we are revoking the company’s companion foreign certificate authority. Instead of 

repeating our findings and conclusions in Order 2011-10-22, we incorporate them here by 

reference.

ACCORDINGLY, 

1. We revoke the certificates of public convenience and necessity issued to Arrow Air, Inc., by 

Order 2000-8-5 and Order 2007-7-4, authorizing it to engage in foreign air transportation.

2. Unless disapproved by the President of the United States under section 41307 of Title 49 of 

the United States Code, this order shall become effective on the 61st day after its submission for 

section 41307 review or upon the date of receipt of advice from the President or his designee 

under Executive Order 12597 and implementing regulations that he or she does not intend to 

disapprove the Department's order under that section, whichever occurs earlier.1

 

1 This order was submitted for section 41307 review on October 28, 2011. The 61st day is December 28, 2011. 

Since the President or his designee did not disapprove this order before that date, it became effective on December 

28, 2011. .

UNITED STATES OF AMERICA DEPARTMENT OF TRANSPORTATION
2

3. We will serve a copy of this order on the persons listed in Attachment A.

By:

TODD M. HOMAN

Director

Office of Aviation Analysis

An electronic version of this document is available on the World Wide Web at:

http://www.regulations.gov
ATTACHMENT A

SERVICE LIST FOR

ARROW AIR, INC.

PETER LYNCH AGC-300

ASST CHIEF COUNSEL FOR 

ENFORCEMENT

FEDERAL AVIATION ADMINISTRATION

800 INDEPENDENCE AVE SW

WASHINGTON DC 20591

ANNE SUISSA RTS-42

OFFICE OF AIRLINE INFORMATION

DOT/RITA/BTS E-34

1200 NEW JERSEY AVE SE

WASHINGTON DC 20590

WILLIAM J WEBER

CERTIFICATION SECTION MANAGER

FAA AFS-900

45005 AVIATION DRIVE SUITE 131

DULLES VA 20166

PIERRE MURPHY

COUNSEL FOR ARROW AIR INC

1200 NEW JERSEY AVE NW

WASHINGTON DC 20036-6802
|FORM 6 - K
|----------



|SECURITIES AND EXCHANGE
COMMISSION  Washington, D.C. 20549
|----------------------------------------------------------



|Report of Foreign Private
Issuer  Pursuant to Rule 13a - 16 or 15d - 16 of  the Securities Exchange Act of 1934
|---------------------------------------------------------------------------------------------------------------



|As of February 24, 2003
|-----------------------



|TENARIS, S.A.  (Translation of
Registrants name into English)
|--------------------------------------------------------------



|TENARIS, S.A.  23 Avenue
Monterey  2086 Luxembourg  (Address of principal executive offices)
|--------------------------------------------------------------------------------------------



|Indicate by check mark whether
the registrant files or will file  annual reports under cover Form 20-F or 40-F.
|---------------------------------------------------------------------------------------------------------------



|Form 20-F |X| Form 40-F |_|
|---------------------------



|Indicate by check
mark whether the registrant by furnishing the  information contained in this Form is also
thereby furnishing the information to  the Commission pursuant to Rule 12G3-2(b) under
the Securities Exchange Act of  1934.
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|Yes |_|  No |X|
|---------------



|If Yes is marked,
indicate below the file number assigned to the registrant in connection with Rule
12g3-2(b): 82-.
|---------------------------------------------------------------------------------------------------------------------



| |  | 
| |  | 



---





|The attached material is being furnished to the
Securities and Exchange  Commission pursuant to Rule 13a-16 and Form 6 -K under the
Securities Exchange  Act of 1934, as amended. This report contains Tenariss press
release announcing  its plan for the acquisition of remaining minority interests in
Siderca.
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|SIGNATURE
|---------



|Pursuant to the requirements of the Securities
Exchange Act of 1934, the  Registrant has duly caused this report to be signed on its
behalf by the  undersigned, thereunto duly authorized.
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|Date: February 24, 2003
|-----------------------



|Tenaris, S.A.
|-------------



|By: /s/ Cecilia Bilesio
      Cecilia Bilesio
      Corporate Secretary
|-----------------------------------------------------------------------



| |  | 
| |  | 



---
§ 510.7 Consignees of new animal drugs for use in the manufacture of animal feed. ( a ) A new animal drug intended for use in the manufacture of animal feed shall be deemed to be unsafe unless at the time of its removal from the establishment of a manufacturer, packer, or distributor of such drug, such manufacturer, packer, or distributor has an unrevoked written statement from the consignee of such drug, or a notice from the Secretary, to the effect that with respect to the use of such drug in animal feed the consignee: ( 1 ) Holds a license issued under § 515.20 of this chapter; or
( 2 ) Will, if the consignee is not the user of the drug, ship such drug only to a holder of an approved application under § 515.10 of this chapter.
( b ) The requirements of paragraph (a) of this section do not apply: ( 1 ) Where such drugs are intended for export and/or
( 2 ) When the use of such drug in the manufacture of a finished feed has been exempted from the requirements of section 512(m) of the act under the conditions specified by regulations published in part 558 of this chapter.
[40 FR 13807, Mar. 27, 1975, as amended at 64 FR 63203, Nov. 19, 1999]